{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:48:08Z","timestamp":1789555688952,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,4,13]],"date-time":"2014-04-13T00:00:00Z","timestamp":1397347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,4,13]],"date-time":"2014-04-13T00:00:00Z","timestamp":1397347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s00436-014-3882-0","type":"journal-article","created":{"date-parts":[[2014,4,12]],"date-time":"2014-04-12T10:47:52Z","timestamp":1397299672000},"page":"2277-2284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Vaccination with Toxoplasma lysate antigen and CpG oligodeoxynucleotides: comparison of immune responses in intranasal versus intramuscular administrations"],"prefix":"10.1007","volume":"113","author":[{"given":"Mohamed A.","family":"EL-Malky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed A.","family":"Al-Harthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raafat T.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"EL Bali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niveen S.","family":"Saudy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,13]]},"reference":[{"issue":"1","key":"3882_CR1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1086\/315186","volume":"181","author":"CW Angus","year":"2000","unstructured":"Angus CW, Klivington-Evans D, Dubey JP, Kovacs JA (2000) Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents. J Infect Dis 181(1):317\u2013324","journal-title":"J Infect Dis"},{"issue":"4","key":"3882_CR2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.vaccine.2011.10.093","volume":"30","author":"H Asanuma","year":"2012","unstructured":"Asanuma H et al (2012) A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging. Vaccine 30(4):803\u2013812. doi:10.1016\/j.vaccine.2011.10.093","journal-title":"Vaccine"},{"issue":"12","key":"3882_CR3","doi-asserted-by":"publisher","first-page":"6932","DOI":"10.1128\/IAI.68.12.6932-6938.2000","volume":"68","author":"G Cai","year":"2000","unstructured":"Cai G, Kastelein R, Hunter CA (2000) Interleukin-18 (IL-18) enhances innate IL-12-mediated resistance to Toxoplasma gondii. Infect Immun 68(12):6932\u20136938","journal-title":"Infect Immun"},{"key":"3882_CR4","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1749-6632.2011.06266.x","volume":"1238","author":"A Cerutti","year":"2011","unstructured":"Cerutti A et al (2011) Regulation of mucosal IgA responses: Lessons from primary immunodeficiencies. Ann N Y Acad Sci 1238:132\u2013144","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"3882_CR5","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1084\/jem.186.10.1623","volume":"186","author":"RS Chu","year":"1997","unstructured":"Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV (1997) CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 186(10):1623\u20131631","journal-title":"J Exp Med"},{"issue":"23\u201324","key":"3882_CR6","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1016\/j.vaccine.2004.01.058","volume":"22","author":"CL Cooper","year":"2004","unstructured":"Cooper CL et al (2004) Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine. Vaccine 22(23\u201324):3136\u20133143","journal-title":"Vaccine"},{"issue":"2\u20133","key":"3882_CR7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0264-410X(00)00172-9","volume":"19","author":"RS Corral","year":"2000","unstructured":"Corral RS, Petray PB (2000) CpG DNA as a Th1-promoting adjuvant in immunization against Trypanosoma cruzi. Vaccine 19(2\u20133):234\u2013242","journal-title":"Vaccine"},{"issue":"9","key":"3882_CR8","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1093\/infdis\/jis216","volume":"205","author":"LB Costa","year":"2012","unstructured":"Costa LB et al (2012) Novel in vitro and in vivo models and potential new therapeutics to break the vicious cycle of Cryptosporidium infection and malnutrition. J infect Dis 205(9):1464\u20131471","journal-title":"J infect Dis"},{"issue":"3","key":"3882_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.exppara.2012.05.002","volume":"131","author":"NS Daifalla","year":"2012","unstructured":"Daifalla NS, Bayih AG, Gedamu L (2012) Leishmania donovani recombinant iron superoxide dismutase B1 protein in the presence of TLR-based adjuvants induces partial protection of BALB\/c mice against Leishmania major infection. Exp Parasitol 131(3):317\u2013324","journal-title":"Exp Parasitol"},{"issue":"7","key":"3882_CR10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/j.1348-0421.2005.tb03656.x","volume":"49","author":"M El-Malky","year":"2005","unstructured":"El-Malky M et al (2005) Protective effect of vaccination with Toxoplasma lysate antigen and CpG as an adjuvant against Toxoplasma gondii in susceptible C57BL\/6 mice. Microbiol Immunol 49(7):639\u2013646","journal-title":"Microbiol Immunol"},{"issue":"13\u201314","key":"3882_CR11","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/S0264-410X(02)00692-8","volume":"21","author":"A Fachado","year":"2003","unstructured":"Fachado A et al (2003) Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice. Vaccine 21(13\u201314):1327\u20131335","journal-title":"Vaccine"},{"issue":"6","key":"3882_CR12","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S1074-7613(03)00122-5","volume":"18","author":"MI Fernandez","year":"2003","unstructured":"Fernandez MI, Pedron T, Tournebize R, Olivo-Marin JC, Sansonetti PJ, Phalipon A (2003) Anti-inflammatory role for intracellular dimeric immunoglobulin a by neutralization of lipopolysaccharide in epithelial cells. Immunity 18(6):739\u2013749","journal-title":"Immunity"},{"issue":"5","key":"3882_CR13","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1128\/IAI.68.5.2948-2953.2000","volume":"68","author":"BL Freidag","year":"2000","unstructured":"Freidag BL et al (2000) CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis. Infect Immun 68(5):2948\u20132953","journal-title":"Infect Immun"},{"issue":"4","key":"3882_CR14","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1084\/jem.183.4.1929","volume":"183","author":"K Fujihashi","year":"1996","unstructured":"Fujihashi K et al (1996) Gamma\/delta T cell-deficient mice have impaired mucosal immunoglobulin A responses. J Exp Med 183(4):1929\u20131935","journal-title":"J Exp Med"},{"issue":"37","key":"3882_CR15","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.1016\/j.vaccine.2008.06.091","volume":"26","author":"T Fukuiwa","year":"2008","unstructured":"Fukuiwa T et al (2008) A combination of Flt3 ligand cDNA and CpG ODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immunity. Vaccine 26(37):4849\u20134859","journal-title":"Vaccine"},{"issue":"1","key":"3882_CR16","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4049\/jimmunol.146.1.286","volume":"146","author":"RT Gazzinelli","year":"1991","unstructured":"Gazzinelli RT, Hakim FT, Hieny S, Shearer GM, Sher A (1991) Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J Immunol 146(1):286\u2013292","journal-title":"J Immunol"},{"key":"3882_CR17","first-page":"127","volume":"219","author":"RT Gazzinelli","year":"1996","unstructured":"Gazzinelli RT, Amichay D, Sharton-Kersten T, Grunwald E, Farber JM, Sher A (1996) Role of macrophage-derived cytokines in the induction and regulation of cell-mediated immunity to Toxoplasma gondii. Curr Topics Microbiol Immunol 219:127\u2013139","journal-title":"Curr Topics Microbiol Immunol"},{"issue":"4","key":"3882_CR18","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.4049\/jimmunol.170.4.1754","volume":"170","author":"Y Hagiwara","year":"2003","unstructured":"Hagiwara Y et al (2003) Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue. J Immunol 170(4):1754\u20131762","journal-title":"J Immunol"},{"issue":"3","key":"3882_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jcv.2004.03.001","volume":"30","author":"AM Harandi","year":"2004","unstructured":"Harandi AM (2004) The potential of immunostimulatory CpG DNA for inducing immunity against genital herpes: Opportunities and challenges. J Clin Virol Off Publ Pan Am Soc Clin Virol 30(3):207\u2013210","journal-title":"J Clin Virol Off Publ Pan Am Soc Clin Virol"},{"issue":"11","key":"3882_CR20","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/nrmicro2858","volume":"10","author":"CA Hunter","year":"2012","unstructured":"Hunter CA, Sibley LD (2012) Modulation of innate immunity by Toxoplasma gondii virulence effectors. Nat Rev Microbiol 10(11):766\u2013778","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"3882_CR21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1046\/j.1365-3024.1998.00152.x","volume":"20","author":"H Jebbari","year":"1998","unstructured":"Jebbari H, Roberts CW, Ferguson DJ, Bluethmann H, Alexander J (1998) A protective role for IL-6 during early infection with Toxoplasma gondii. Parasite immunol 20(5):231\u2013239","journal-title":"Parasite immunol"},{"issue":"6","key":"3882_CR22","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1128\/IAI.01185-12","volume":"81","author":"KD Jensen","year":"2013","unstructured":"Jensen KD et al (2013) Toxoplasma gondii rhoptry 16 kinase promotes host resistance to oral infection and intestinal inflammation only in the context of the dense granule protein GRA15. Infect Immun 81(6):2156\u20132167","journal-title":"Infect Immun"},{"issue":"5","key":"3882_CR23","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.4049\/jimmunol.164.5.2629","volume":"164","author":"H Kang","year":"2000","unstructured":"Kang H, Remington JS, Suzuki Y (2000) Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase. J Immunol 164(5):2629\u20132634","journal-title":"J Immunol"},{"issue":"8","key":"3882_CR24","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/j.vaccine.2009.10.094","volume":"28","author":"DM Klinman","year":"2010","unstructured":"Klinman DM, Klaschik S, Tomaru K, Shirota H, Tross D, Ikeuchi H (2010) Immunostimulatory CpG oligonucleotides: Effect on gene expression and utility as vaccine adjuvants. Vaccine 28(8):1919\u20131923","journal-title":"Vaccine"},{"issue":"2","key":"3882_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S1471-4906(01)02150-0","volume":"23","author":"AM Krieg","year":"2002","unstructured":"Krieg AM (2002) From A to Z on CpG. Trends Immunol 23(2):64\u201365","journal-title":"Trends Immunol"},{"issue":"2","key":"3882_CR26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/nat.2012.0340","volume":"22","author":"AM Krieg","year":"2012","unstructured":"Krieg AM (2012) CpG still rocks! Update on an accidental drug. Nucleic Acid Ther 22(2):77\u201389","journal-title":"Nucleic Acid Ther"},{"issue":"6","key":"3882_CR27","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/00002371-200411000-00006","volume":"27","author":"AM Krieg","year":"2004","unstructured":"Krieg AM, Efler SM, Wittpoth M, Al Adhami MJ, Davis HL (2004) Induction of systemic TH1-like innate immunity in normal volunteers following subcutaneous but not intravenous administration of CPG 7909, a synthetic B-class CpG oligodeoxynucleotide TLR9 agonist. J Immunother 27(6):460\u2013471","journal-title":"J Immunother"},{"issue":"7","key":"3882_CR28","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1002\/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U","volume":"31","author":"A Krug","year":"2001","unstructured":"Krug A et al (2001) Identification of CpG oligonucleotide sequences with high induction of IFN-alpha\/beta in plasmacytoid dendritic cells. Eur J Immunol 31(7):2154\u20132163","journal-title":"Eur J Immunol"},{"issue":"2","key":"3882_CR29","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1128\/IAI.72.2.949-957.2004","volume":"72","author":"S Kumar","year":"2004","unstructured":"Kumar S et al (2004) CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccine. Infect Immun 72(2):949\u2013957","journal-title":"Infect Immun"},{"issue":"1","key":"3882_CR30","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1086\/314827","volume":"180","author":"Y Kurono","year":"1999","unstructured":"Kurono Y et al (1999) Nasal immunization induces Haemophilus influenzae-specific Th1 and Th2 responses with mucosal IgA and systemic IgG antibodies for protective immunity. J infect Dis 180(1):122\u2013132","journal-title":"J infect Dis"},{"issue":"6506","key":"3882_CR31","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/372552a0","volume":"372","author":"S Langermann","year":"1994","unstructured":"Langermann S, Palaszynski S, Sadziene A, Stover CK, Koenig S (1994) Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi. Nature 372(6506):552\u2013555","journal-title":"Nature"},{"issue":"6","key":"3882_CR32","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1046\/j.1365-3024.1999.00228.x","volume":"21","author":"YH Lee","year":"1999","unstructured":"Lee YH, Ely KH, Lepage A, Kasper LH (1999) Interleukin-15 enhances host protection against acute Toxoplasma gondii infection in T-cell receptor alpha-\/-deficient mice. Parasite immunol 21(6):299\u2013306","journal-title":"Parasite immunol"},{"issue":"1","key":"3882_CR33","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00436-009-1393-1","volume":"105","author":"S Liu","year":"2009","unstructured":"Liu S, Shi L, Cheng YB, Fan GX, Ren HX, Yuan YK (2009) Evaluation of protective effect of multi-epitope DNA vaccine encoding six antigen segments of Toxoplasma gondii in mice. Parasitol Res 105(1):267\u2013274","journal-title":"Parasitol Res"},{"issue":"1","key":"3882_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/mi.2007.6","volume":"1","author":"AJ Macpherson","year":"2008","unstructured":"Macpherson AJ, McCoy KD, Johansen FE, Brandtzaeg P (2008) The immune geography of IgA induction and function. Mucosal Immunol 1(1):11\u201322","journal-title":"Mucosal Immunol"},{"issue":"9","key":"3882_CR35","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.vaccine.2012.12.071","volume":"31","author":"L Ramirez","year":"2013","unstructured":"Ramirez L et al (2013) Evaluation of immune responses and analysis of the effect of vaccination of the Leishmania major recombinant ribosomal proteins L3 or L5 in two different murine models of cutaneous leishmaniasis. Vaccine 31(9):1312\u20131319","journal-title":"Vaccine"},{"issue":"26","key":"3882_CR36","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1016\/j.vaccine.2012.03.040","volume":"30","author":"VH Shargh","year":"2012","unstructured":"Shargh VH et al (2012) Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis. Vaccine 30(26):3957\u20133964","journal-title":"Vaccine"},{"issue":"3","key":"3882_CR37","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/cei.12074","volume":"172","author":"S Srivastava","year":"2013","unstructured":"Srivastava S, Pandey SP, Jha MK, Chandel HS, Saha B (2013) Leishmania expressed lipophosphoglycan interacts with Toll-like receptor (TLR)-2 to decrease TLR-9 expression and reduce anti-leishmanial responses. Clin Exp Immunol 172(3):403\u2013409","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"3882_CR38","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.2353\/ajpath.2010.090825","volume":"176","author":"Y Suzuki","year":"2010","unstructured":"Suzuki Y et al (2010) Removal of Toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+ T cells. Am J Pathol 176(4):1607\u20131613","journal-title":"Am J Pathol"},{"issue":"1","key":"3882_CR39","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.micinf.2012.10.007","volume":"15","author":"T Teixeira de Melo","year":"2013","unstructured":"Teixeira de Melo T, Araujo JM, Campos de Sena I, Carvalho Alves C, Araujo N, Toscano Fonseca C (2013) Evaluation of the protective immune response induced in mice by immunization with Schistosoma mansoni schistosomula tegument (Smteg) in association with CpG-ODN. Microbes Infect Institut Pasteur 15(1):28\u201336","journal-title":"Microbes Infect Institut Pasteur"},{"issue":"2","key":"3882_CR40","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.femsim.2004.05.008","volume":"42","author":"P Tewary","year":"2004","unstructured":"Tewary P, Pandya J, Mehta J, Sukumaran B, Madhubala R (2004) Vaccination with Leishmania soluble antigen and immunostimulatory oligodeoxynucleotides induces specific immunity and protection against Leishmania donovani infection. FEMS immunol Med Microbiol 42(2):241\u2013248","journal-title":"FEMS immunol Med Microbiol"},{"issue":"2\u20133","key":"3882_CR41","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S0264-410X(97)00194-1","volume":"16","author":"K Tochikubo","year":"1998","unstructured":"Tochikubo K et al (1998) Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin. Vaccine 16(2\u20133):150\u2013155","journal-title":"Vaccine"},{"issue":"4","key":"3882_CR42","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/eji.1830250417","volume":"25","author":"J Vadolas","year":"1995","unstructured":"Vadolas J, Davies JK, Wright PJ, Strugnell RA (1995) Intranasal immunization with liposomes induces strong mucosal immune responses in mice. Eur J Immunol 25(4):969\u2013975","journal-title":"Eur J Immunol"},{"issue":"11","key":"3882_CR43","doi-asserted-by":"publisher","first-page":"6850","DOI":"10.4049\/jimmunol.173.11.6850","volume":"173","author":"N Yoshino","year":"2004","unstructured":"Yoshino N et al (2004) A novel adjuvant for mucosal immunity to HIV-1 gp120 in nonhuman primates. J Immunol 173(11):6850\u20136857","journal-title":"J Immunol"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-014-3882-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00436-014-3882-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-014-3882-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-014-3882-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:02:49Z","timestamp":1744149769000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00436-014-3882-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,13]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["3882"],"URL":"https:\/\/doi.org\/10.1007\/s00436-014-3882-0","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,13]]},"assertion":[{"value":"3 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}